Results of a multicenter, phase 2 study of nivolumab and ipilimumab for patients with advanced rare genitourinary malignancies

Bradley Alexander McGregor, Matthew Campbell, Wanling Xie, Subrina Farah, Mehmet A. Bilen, Andrew L. Schmidt, Guru P. Sonpavde, Kerry L. Kilbridge, Atish D. Choudhury, Amir Mortazavi, Amishi Y. Shah, Aradhana M. Venkatesan, Glenn J. Bubley, Arlene O. Siefker-Radtke, Rana R. McKay, Toni K. Choueiri

Research output: Contribution to journalArticlepeer-review

50 Scopus citations

Fingerprint

Dive into the research topics of 'Results of a multicenter, phase 2 study of nivolumab and ipilimumab for patients with advanced rare genitourinary malignancies'. Together they form a unique fingerprint.

Medicine & Life Sciences